DOTBIO
Who is DOTBIO?
DotBio is a biotechnology company focused on developing novel immuno-oncology drugs using its proprietary DotBody technology. Dot Bodies are multi-specific, humanized, and highly stable domain therapeutic antibodies that have the potential to revolutionize cancer treatment. Founded by experts in pro...See more
Industry & Specialities
Others
Countries of Operation
Singapore
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2018 (8 years)
Address:
1 RESEARCH LINK; SINGAPORE, 11, SG
Employees by Department
- IT / Product (1)
- Operations (1)
- Sales (1)
- The Rest (14)
- Total (17)
Key Decision Makers
Shimin Jiang
Senior Scientist
Lui Ke Xin
Business Development Executive
Chan Kiat Yew
R&D intern
Henrik Engman
Scientist
Insight
Signals
At a glanceThe company has corporate shareholder(s) or more than 20 individual shareholders
The company has a sophisticated ownership structure and may be part of a large corporate group
* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.
Employees by Seniority
C-level
2employees
Senior
1employees
Non-managers
13employees
Financials
LOW
spending power
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has DOTBIO been operating for?
- What is the funding status of DOTBIO?
- Where is DOTBIO's headquarter?
- What DOTBIO's spending power?
- Does DOTBIO have a presence in the domain it operates in?